articles

Synectics – a buy for recovery

Tom Winnifrith Thursday 11 October 2018

 

Share this

Having been over 600p in 2013, shares in Synectics (SNX) were heading towards 100p towards the end of 2014 following a “Trading Update and Board Changes” announcement, which included from Chairman David Coghlan; “In the board's view, and I'm sure that of other shareholders, a third profits warning in a year for Synectics is unacceptable, even after five years of solid profits growth. Some of the factors behind this poor performance have been outside the company's control, but others were not. Action is being taken to ensure future profitability is not dependent on the timing of revenue recovery in certain sectors”. Such action looks to have been taken, but the share price has only recovered to a current 220p offer – and this looks a recovery story with more to go…

Read the full article on ShareProphets | Comments
About Tom Winnifrith
Bio
Tom Winnifrith is the editor of TomWinnifrith.com. When he is not harvesting olives in Greece, he is (planning to) raise goats in Wales.
Twitter
@TomWinnifrith
Email
[email protected]
Read next

BREAKING: Versarien Patrick Abbott update – oh dear he now faces up to 20 years in jail, lawyer quits

Oh dear, oh Dear. You may remember how on March 21, Versarien (VRS) announced with great fanfate that it had appointed Patrick Abbott to spearhead its US expansion. Lucian Miers then pointed out that Mr Abbott faced a few legal problems. And so on April 4 Versarien stated:

On ShareProphets
Saturday 15 June 2019
TomWinnifrith.com Copyright © . All rights reserved.
Created by Everywhen